Concepedia

Kerry Jenkins

KJ

Statistics

Publications

16

Citations

510

H-Index

15

Active since

1996

Affiliations

Granta Design (United Kingdom)(Current)

University of Sussex

Universidade Nova de Lisboa

UCB Pharma (United Kingdom)

GlaxoSmithKline (United Kingdom)

Kerry Jenkins is an author at Granta Design (United Kingdom) specializing in medicinal chemistry, enzyme inhibition, and pharmacology.

ORCID

Publications per year

1996–2017

16

Publications

16

Intramolecular radical substitution reactions: a novel approach to fused [1,2-a] indoles

Stephen Caddick, Karim Aboutayab, Kerry Jenkins et al. · Journal of the Chemical Society Perkin Transactions 1 · 1996 · 62 citations

, , +17

IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine binding

George M. Buckley, T.A. Ceska, Joanne L. Fraser et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 52 citations · Full text

, , +15

IRAK-4 inhibitors. Part III: A series of imidazo[1,2-a]pyridines

George M. Buckley, Richard Fosbeary, Joanne L. Fraser et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 51 citations · Full text

, , +11

A new dynamic resolution strategy for asymmetric synthesis

Stephen Caddick, Kerry Jenkins · Tetrahedron Letters · 1996 · 42 citations

, , +4

IRAK-4 inhibitors. Part 1: A series of amides

George M. Buckley, Lewis Gowers, Alícia P. Higueruelo et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 37 citations · Full text

, , +8

1–5 of 16